Abstract:The human ether-à-go-go-1 (h-eag1) K(+) channel is expressed in a variety of cell lines derived from human malignant tumors and in clinical samples of several different cancers, but is otherwise absent in normal tissues. It was found to be necessary for cell cycle progression and tumorigenesis. Specific inhibition of h-eag1 expression leads to inhibition of tumor cell proliferation. We report here that h-eag1 expression is controlled by the p53-miR-34-E2F1 pathway through a negative feed-forward mechanism. We first established E2F1 as a transactivator of h-eag1 gene through characterizing its promoter region. We then revealed that miR-34, a known transcriptional target of p53, is an important negative regulator of h-eag1 through dual mechanisms by directly repressing h-eag1 at the post-transcriptional level and indirectly silencing h-eag1 at the transcriptional level via repressing E2F1. There is a strong inverse relationship between the expression levels of miR-34 and h-eag1 protein. H-eag1antisense antagonized the growth-stimulating effects and the upregulation of h-eag1 expression in SHSY5Y cells, induced by knockdown of miR-34, E2F1 overexpression, or inhibition of p53 activity. Therefore, p53 negatively regulates h-eag1 expression by a negative feed-forward mechanism through the p53-miR-34-E2F1 pathway. Inactivation of p53 activity, as is the case in many cancers, can thus cause oncogenic overexpression of h-eag1 by relieving the negative feed-forward regulation. These findings not only help us understand the molecular mechanisms for oncogenic overexpression of h-eag1 in tumorigenesis but also uncover the cell-cycle regulation through the p53-miR-34-E2F1-h-eag1 pathway. Moreover, these findings place h-eag1 in the p53-miR-34-E2F1-h-eag1 pathway with h-eag as a terminal effecter component and with miR-34 (and E2F1) as a linker between p53 and h-eag1. Our study therefore fills the gap between p53 pathway and its cellular function mediated by h-eag1.

E2F1: a Potential Negative Regulator of Htert Transcription in Normal Cells Upon Activation of Oncogenic C-Myc.

YY1 Promotes Colorectal Cancer Proliferation Through the Mir-526B-3p/e2f1 Axis.

ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs

Ets2 Maintains Htert Gene Expression and Breast Cancer Cell Proliferation by Interacting with C-Myc.

c-Myc-regulated microRNAs modulate E2F1 expression

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

MYC Protein Inhibits Transcription of the MicroRNA Cluster MC-let-7a-1∼let-7d Via Noncanonical E-box

Transcript Regulation of Human Telomerase Reverse Transcriptase by C-Myc and Mad1.

Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2

Transcriptional and Post-Transcriptional Mechanisms for Oncogenic Overexpression of Ether À Go-Go K+ Channel

Transcriptional Regulation of Telomerase Activity

[Influence of RNA Interference Targeting Against Human Telomerase Reverse Transcriptase on Expression of C-myc Protein].

The Map3k13-Trim25-Fbxw7 Alpha Axis Affects C-Myc Protein Stability And Tumor Development

EAG K+ channel joins the p53&x2212;miR-34&x2212;E2F1 signaling pathway as a terminal effecter component for its oncogenic overexpression and action

E2F-1 Targets Mir-519D to Regulate the Expression of the Ras Homolog Gene Family Member C

Distinct Functions of Transforming Growth Factor-Β Signaling in C-Myc Driven Hepatocellular Carcinoma Initiation and Progression.

Molecular Insights of c-Myc in Cellular Senescence

E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375

A C-Myc/Mir-17-5p Feedback Loop Regulates Metastasis and Invasion of Hepatocellular Carcinoma

EAG K+ channel joins the p53xmiR-34xE2F1 signaling pathway as a terminal effecter component for its oncogenic overexpression and action

A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis.